In the liver, a protective effect of PPARα on the development of NASH and inflammation was shown by down-regulation of nuclear factor kappa-light-chain-enhancer of activated B cells, activator protein 1, STATs, and interleukin 6.40 Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.